HomeSPH • WSE
add
Sopharma AD
Market news
Financials
Income Statement
Revenue
Net income
| (BGN) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 641.57M | 18.09% |
Operating expense | 113.18M | 20.36% |
Net income | 40.38M | 117.21% |
Net profit margin | 6.29 | 83.92% |
Earnings per share | — | — |
EBITDA | 73.29M | 100.31% |
Effective tax rate | 10.72% | — |
Balance Sheet
Total assets
Total liabilities
| (BGN) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.65M | -14.31% |
Total assets | 2.02B | 28.05% |
Total liabilities | 1.04B | 41.19% |
Total equity | 981.36M | — |
Shares outstanding | 519.26M | — |
Price to book | 6.82 | — |
Return on assets | 5.55% | — |
Return on capital | 7.01% | — |
Cash Flow
Net change in cash
| (BGN) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 40.38M | 117.21% |
Cash from operations | 11.54M | -53.55% |
Cash from investing | -17.80M | -430.27% |
Cash from financing | 4.36M | 123.56% |
Net change in cash | -1.90M | -116.13% |
Free cash flow | -16.10M | -38.00% |
About
Founded
1933
Website
Employees
5,905
